The partnership will investigate Jellagen’s Collagen Type 0 as the core collagen biomaterial for several, ground-breaking new solutions in regenerative medicine.
READ POSTJellagen developed JellaGel to offer a viable alternative to Matrigel and in this article, we will compare the two.
READ POSTNew partnership between Jellagen and Cellaria Inc. offers paradigm shift in collagen chemistry to develop next-generation models for cancer research
READ POSTJellagen and Copner Biotech ink partnership following SMART Cymru innovation funding award of £123,724
READ POSTFull Time, Permanent - Cardiff, Wales
READ POSTProfessor Sheila MacNeil is Emeritus Professor of Tissue Engineering at the Department of Materials Science and Engineering, University of Sheffield.
READ POSTIfremer is recognized throughout the world as one of the very first institutes in marine science and technology
READ POSTDiscover how JellaGel compares to Matrigel & how it can successfully support Mouse Embryonic Stem Cells (mESCs)
READ POSTDiscover how JellaGel can help simplify and improve your cancer spheroid research
READ POSTISO 13485 is a Quality Management System (QMS) standard taken from the internationally recognized ISO 9000 quality management standard series.
READ POST© 2022 Jellagen. All rights reserved. Company Registration No. SC451036
